Menu

• Ask a Health Expert about INJECTION SITE FIBROSIS
• Post Your Side Effect related to INJECTION SITE FIBROSIS
• INJECTION SITE FIBROSIS and FDA Warnings
• INJECTION SITE FIBROSIS in Patients Wiki
• Report INJECTION SITE FIBROSIS in Drug Side Effect Survey

INJECTION SITE FIBROSIS side effect

What is INJECTION SITE FIBROSIS ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Rebif Side Effects Report #5318550-2
Physician from UNITED STATES reported REBIF problem on Apr 17, 2007. Female patient, 47 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: injection site fibrosis, injection site infection, . REBIF dosage: unknown. Patient recovered.

Rebif Side Effects Report #5330112-X
REBIF problem was reported by a Physician from UNITED STATES on May 01, 2007. Female patient, 47 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: injection site fibrosis, injection site infection, . REBIF dosage: unknown. Patient recovered.

Kineret Side Effects Report #5509732-5
Health Professional from UNITED STATES reported KINERET problem on Nov 07, 2007. Male patient, 53 years of age, weighting 195.0 lb, was diagnosed with juvenile arthritis, psoriatic arthropathy and was treated with KINERET. After drug was administered, patient experienced the following problems/side effects: injection site abscess, injection site fibrosis, injection site reaction, musculoskeletal disorder, skin disorder, . KINERET dosage: 100MG. Q.D./S.C.. During the same period patient was treated with DOLOBID, COZAAR, AZULFIDINE, ISOCORT. Patient was hospitalized. Patient recovered.

Voltaren Side Effects Report #5360200-3
VOLTAREN problem was reported by a Physician from FRANCE on June 04, 2007. Female patient, 48 years of age, was diagnosed with back pain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, injection site discolouration, injection site fibrosis, injection site reaction, . VOLTAREN dosage: 75 MG, UNK. During the same period patient was treated with COLTRAMYL. Patient recovered.